Abstract:Cytochrome P450 sterol 14 alpha-demethylases (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs. All fungal CYP51s are integral membrane proteins, making structural and biophysical characterization more challenging. The X-ray crystallographic structure of CYP51 isolated from Mycobacterium tuberculosis (MT-CYP51) is the unique reported one hitherto. In the present study, a homology modeling three-dimensional structure of CYP51 from Penicillium digitatum (PD-CYP51) was generated by CPHmodels, in which the accuracy of sequence alignment Could be improved by taking into account further Structural conservation information, using NIT-CYP51 as the template. Interaction mechanism between the active site of PD-CYP51 and its inhibitors were further investigated by molecular dynamics Simulating and molecular docking. With the effective docking process and interaction analysis information, structure-based virtual screening was performed to pick out the thirty new potential inhibiting compounds with structural diversity by using a new virtual screening strategy including Flex-Pharm/PMF/GOLD//FlexX/ PMF/GOLD molecular docking procedures, and finally, seven new hit compounds out of SPECs database with potent inhibitory ability were validated by bioaffinity assays Lit enzyme level and on P. digitatum in vitro. The positive results indicated that all modeling strategies and screening processes presented ill the Current study most like to be an encouraging way in search of novel lead compounds with Structural diversity for the specifically individual fungal CYP51s of both plants and human pathogens in the future.

The discovery of novel antifungal phenylpyridines derivatives based on CYP53 binding model

Structure-based Virtual Screening and ADME/T-based Prediction Analysis for the Discovery of Novel Antifungal CYP51 Inhibitors.

Design,Synthesis and Antifungal Activity of Novel Pyrazole-Thiophene Carboxamide Derivatives

Discovery of Biphenyl Imidazole Derivatives As Potent Antifungal Agents: Design, Synthesis, and Structure-Activity Relationship Studies.

Synthesis and biological evaluation of triazole derivatives as potential antifungal agent.

Identification of novel and potent triazoles targeting CYP51 for antifungal: Design, synthesis, and biological study

Structure-Based Rational Screening of Novel Hit Compounds with Structural Diversity for Cytochrome P450 Sterol 14α-Demethylase from Penicillium digitatum.

Comparison and analysis of the structures and binding modes of antifungal SE and CYP51 inhibitors

Synthesis, In Vitro Biological Evaluation, and Molecular Docking of New Triazoles as Potent Antifungal Agents.

Design, Synthesis, and Biological Evaluation of Dual-Target COX-2/CYP51 Inhibitors for the Treatment of Fungal Infectious Diseases.

Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).

Design, Synthesis, and Biological Evaluation of Novel Triazole Derivatives As Inhibitors of Cytochrome P450 14Α-Demethylase.

Construction and activity evaluation of novel dual-target (SE/CYP51) anti-fungal agents containing amide naphthyl structure

Design, Synthesis and Bioactivity Evaluation of Novel Arylalkene-Amide Derivatives As Dual-Target Antifungal Inhibitors

Construction and Activity Evaluation of Novel Benzodioxane Derivatives As Dual-Target Antifungal Inhibitors.

Discovery of novel triazoles containing benzyloxy phenyl isoxazole side chain with potent and broad-spectrum antifungal activity

Novel Naphthylamide Derivatives As Dual-Target Antifungal Inhibitors: Design, Synthesis and Biological Evaluation.

Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance

Molecular Docking, Design, Synthesis and Antifungal Activity Study of Novel Triazole Derivatives Containing the 1,2,3-Triazole Group

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Design, Synthesis, and Antifungal Activities of Novel 1H-Triazole Derivatives Based on the Structure of the Active Site of Fungal Lanosterol 14α-Demethylase (CYP51)